Latest News in the pharma Industry

Rx-360 Summary of EU’s Falsified Medicines Directive rule (Article 46b 2011/62/EU)

8 Jun 2013

Rx-360 Summary of Guidance for Industry and FDA Staff: Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products

8 May 2013

Novartis Drug Lucentis Approved in EU as First Effective Anti-VEGF Treatment for Myopic Choroidal Neovascularization

7 May 2013

New FDA Regulation Gives the Agency More Power During an Inspection

9 Apr 2013

RAPS Releases New Edition of Essential US Regulatory Affairs Reference Book

7 Apr 2013

Breast Cancer Drug Approved for Use in Wales

9 Mar 2013

Sunshine Act to cast a light on physician interactions with drug makers

26 Feb 2013

The National Physician Payment Transparency Program aims to pull back the curtain on physician-pharmaceuticals relations.

US FDA norms on Clinical Pharmacogenomics may provide clear rules for new drug devpt

16 Feb 2013

The US Food and Drug Administration (FDA) has now issued the guidance for Industry on Clinical Pharmacogenomics which refers to a Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for labelling.

Govt forms panels to frame guidelines & SOPs for approval of new drugs, trials, banning drugs

16 Feb 2013

The Union health ministry has constituted two expert committees to formulate policy guidelines and standard operating procedures (SOPs) for approval of new drugs, clinical trials, banning of drugs and Fixed Dose Combinations (FDCs).

Parliamentary panel recommends bringing of CDSCO under Dept of Pharmaceuticals

16 Feb 2013

Parliamentary panel attached to the Ministry of Chemicals and Fertilisers has asked the Ministry to check on quality of drugs.

New Requirements of the FDA on Stability Testing of Generic Drugs

8 Feb 2013

Recipharm AB Provides access to Asmasal Clickhaler Dossier for Vectura plc Chinese Market Approval

7 Feb 2013